BioLineRx (NASDAQ: BLRX) Reports Promising Results Of Motixafortide In Phase III Trial
Hasnain Khan
October 30, 2020
Shares of BioLineRx Ltd. (NASDAQ: BLRX) traded up 52.03% in the pre-market session after the company has reported the encouraging results from the GENESIS Phase